• share
• favorite_border

• share
• favorite_border

Researchers from the University of Arkansas for Medical Sciences (UAMS) have discovered that an FDA-approved cholesterol drug holds the potential to disrupt the progression of Alzheimer's disease and other forms of dementia.

• share
• favorite_border

The results of an international clinical trial led by Michael Birrer, M.D., Ph.D., director of the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS), on the use of a novel bispecific antibody for women with recurrent or metastatic cervical cancer were published today in JAMA Oncology.

• share
• favorite_border

A potential new drug to prevent Alzheimer’s disease in people with the so-called Alzheimer’s gene has been discovered by a University of Arkansas for Medical Sciences (UAMS) research team led by Sue Griffin, Ph.D.

• share
• favorite_border

The Proton Center of Arkansas opened today at the University of Arkansas for Medical Sciences (UAMS), becoming the first proton therapy center in Arkansas and only the 43rd in the nation to provide the most advanced cancer radiation treatment in the world.

• share
• favorite_border

The Birrer Laboratory at the University of Arkansas for Medical Sciences (UAMS) Winthrop P. Rockefeller Cancer Institute helped discover a proteogenomic signature in ovarian cancer that may improve the way the disease is treated around the world. The discovery, which identifies a 64-protein-gene signature that can predict primary treatment resistance in patients with high grade ovarian cancer, was published Aug. 3 in the journal Cell.

• share
• favorite_border

The first Arkansan and only second person in the world has received an innovative prosthetic hand, developed by researchers at the Institute for Integrative and Innovative Research (I³R), that restores a meaningful sense of touch and grip force following surgery at the University of Arkansas for Medical Sciences (UAMS).

• share
• favorite_border

Researchers from the University of Arkansas for Medical Sciences (UAMS) evaluated the accuracy of various hearing screening tools in a rural school setting in a recent article published by Ear and Hearing, the official journal of the American Auditory Society.

• share
• favorite_border

The Children’s Tumor Foundation (CTF) and the University of Arkansas for Medical Sciences (UAMS) announced the opening of the first CTF-sponsored, fully multidisciplinary clinic dedicated to the care of adults with neurofibromatosis (NF) at the UAMS Winthrop P. Rockefeller Cancer Institute.

• share
• favorite_border

The Hearing Norton Sound study, which focused on school-based hearing screening programs in rural Alaska, showed that referring children to specialists via telemedicine provides significantly quicker access to follow-up care than referring them to primary care providers.

• share
• favorite_border

Results of a 12-month multicenter randomized clinical trial led by Erika Petersen, M.D., a professor of neurosurgery at the University of Arkansas for Medical Sciences (UAMS), were published online Nov. 29 in Diabetes Care, highlighting the benefits of a breakthrough treatment for patients with painful diabetic neuropathy (PDN).

• share
• favorite_border

The University of Arkansas for Medical Sciences (UAMS) has received $18.9 million from the National Institutes of Health (NIH) to support new research and interventions that will focus on reducing cancer and cardiovascular disease disparities among people who live in rural areas and African American populations across Arkansas.

• share
• favorite_border

A research team has identified a potential cause of long-lasting symptoms experienced by COVID-19 patients, often referred to as long-haulers. The findings were published in the journal, The Public Library of Science ONE (PLOS ONE).